Relaxin and breast cancer

Bulletin du Cancer

Volumn 84, Issue 2, 1997, Pages 179-182

  Bani, Danièle ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

breast cancer; mammary gland; MCF 7 cells; relaxin

Indexed keywords

RELAXIN;

BREAST CANCER; CARCINOMA CELL; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; REVIEW; TUMOR GROWTH;

ADENOCARCINOMA; BREAST; BREAST NEOPLASMS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; DNA, NEOPLASM; FEMALE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RELAXIN; TUMOR CELLS, CULTURED;

EID: 0030904978     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Ahmed A. The myoepithelium in human breast carcinoma. J Pathol 1974; 113: 129-35.
2. Bani G, Bigazzi M, Bani-Sacchi T. Relaxin as a mammotrophic hormone. Exp Clin Endocrinol (Life Sci Adv) 1991; 10: 143-50.
3. Bani D, Riva A, Bigazzi M, Bani-Sacchi T. Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin. Br J Cancer 1994; 70: 900-4.
4. Bani D, Bigazzi M, Masini E, Bani G, Bani-Sacchi T. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab Invest 1995a; 75: 709-16.
5. Bani D, Masini E, Bello MG, Bigazzi M, Bani-Sacchi T. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995b; 55: 5272-5.
6. Bani D. Relaxin: a pleiotrophic hormone. Gen Pharmacol 1996; 27 (in press).
7. Bani-Sacchi T, Bani D, Brandi ML, Falchetti A, Bigazzi M. Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture. Int J Cancer 1994; 57: 129-34.
8. Bani-Sacchi T, Bigazzi M, Bani D, Mannaioni PF, Masini E. Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol 1995; 116: 1589-94.
9. Behrens J, Mareel MM, van Roy FM, Birchmeyer W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-47.
10. Bigazzi M, Brandi ML, Bani G, Bani-Sacchi T. Relaxin influences the growth of MCF-7 breast cancer cells. Mitogenic and antimitogenic action depends on peptide concentration. Cancer 1992; 70: 639-43.
11. Bigazzi M, Bani-Sacchi T, Bani G. Relaxin and the mammary gland. In: MacLennan AH, Tregear G, Bryant-Greenwood GD, eds. Progress in relaxin research. Singapore: World Scientific Publishing, 1995a: 541-51.
12. Bigazzi M, Bani D, Bani G, Bani-Sacchi T. Relaxin and the cardiocirculatory system. In: MacLennan AH, Tregear G, Bryant-Greenwood GD, eds. Progress in relaxin research. Singapore: World Scientific Publishing, 1995b: 499-507.
13. Boller K, Vestweber D, Kemler R. Cell adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells. J Cell Biol 1985; 100: 327-32.
14. Brycnt-Greenwood GD. Relaxin as a new hormone. Endocrine Reviews 1982; 3: 62-90.
15. Bryant-Greenwood GD, Schwabe C. Human relaxins: chemistry and biology. Endocrine Reviews 1994; 15: 5-26.
16. Cho-Chung YS, Clair T, Bodwin JS, Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 1981; 214: 77-9.
17. Cutts JH. Estrogen-induced breast cancer in the rat. Can Cancer Conf 1966; 65: 50-68.
18. Fei DTW, Gross MC, Lofgren JL, Mora-Worms M, Chen AB. Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells - a specific and high throughput in vitro bioassay. Biochem Biophys Res Commun 1990; 170: 214-22.
19. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Loechner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
20. Gallo O, Bani D, Toccafondi G, Almerigogna F, Fini-Storchi O. Characterization of a novel cell line from pleomorphic adenoma of the parotid gland with myoepithelial phenotype and producing interleukin-6 as an autocrine growth factor. Cancer 1992; 70: 559-68.
21. Galio O, Bani D, Giudizi MG, Biagiotti R, Almerigogna F, Toccafondi G, Fini-Storchi O, Romagnani S. Spontaneous in vitro differentiation of a myoepithelial cell line from a pleomorphic adenoma of the parotid gland is associated with reduced production of the autocrine growth factor interleukin-6. Brit J Cancer 1994; 69: 1065-71.
22. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988; 107: 1575-87.
23. Hamolsky M, Sparrow RC. Influence of relaxin on mammary development in sexually immature female rats. Proc Soc Exp Biol Med 1945; 60: 8-9.
24. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235: 473-6.
25. Hsu CJ, McCormack SM, Sanborn BM. The effect of relaxin on cyclic adenosine 3′5′-monophosphate concentrations in rat myometrial cells in culture. Endocrinology 1985; 116: 2029-35.
26. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485-90.
27. Kitajima K, Yamashita K, Fujita H. Fine structural aspects of follicle-like cavity formation from dispersed porcine thyroid cells cultured in a collagen substrate. Arch Histol Jap 1987; 50: 113-27.
28. Kramer SM, Gibson UEM, Fendly BM, Mohler MA, Drolet DW, Johnston PD. Increase in cyclic AMP levels by relaxin in human rhesus monkey uterus cell culture. In Vitro Cell Dev Biol 1990; 26: 647-56.
29. Lepoivre M, Boudbid H, Petit JF. Antiproliferatie activity of γ-interferon combined with lipopolysaccharide on murine adenocarcinoma: dependence on an L-arginine metabolism with production of nitrite and citrulline. Cancer Res 1989; 49: 1970-7.
30. Lepoivre M, Chenais B, Yapo A, Lemaire G, Thelander L, Tenu JP. Alteration of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990; 265: 14143-9.
31. Mareel M, Vleminckx K, Vermeulen S, Gao Y, Vakaet L, Bracke M, van Roy F. Homotypic cell-cell adhesion molecules and tumor invasion. Progr Histochem Cytochem 1992; 26: 95-106.
32. Masini E, Bani D, Bigazzi M, Mannaioni PF, Bani-Sacchi T. Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J Clin Invest 1994; 94: 1974-80.
33. Miller WR. Interactions between malignant and non-malignant components of the breast. In: Dogliotti L, Sapino A, Bussolati G, eds. Breast cancer: biological and clinical progress. Boston: Kluwer, 1992: 119-36.
34. Munoz-Fernandez MA, Cano E, O'Donnell CA, Doyle J, Lieuw FY, Fresno M. Tumor necrosis factor-alpha (TNF-alpha), interferon-gamma and interleukin-6 but not TNF-beta induce differentiation of neuroblastoma cells: the role of nitric oxide. J Neurochem 1994; 62: 1330-6.
35. Nardi E, Bigazzi M, Agrimonti F, Dogliotti L, Massi GB, Ferrari M, Ciardetti P, De Luca V, Angeli A. Relaxin and fibrocystic disease of the mammary gland. In: Bigazzi M, Greenwood FC, Gasparri F, eds. Biology of relaxin and its role in the human. Amsterdam: Excerpta Medico, 1983; 417-9.
36. Radomski MW, Jenkins DC, Holmes L, Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 1991; 51: 6073-8.
37. Sakakura T. New aspects of stroma-parenchyma relations in mammary gland differentiation. Int Rev Cytol 1991; 125: 165-202.
38. Sanborn BM, Kuo HS, Weisbrodt NW, Sherwood OD. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 1980; 106: 1210-5.
39. Schwabe C, Büllesbach EE. Relaxin: structures, functions, promises, and nonevolution. FASEB J 1994; 8: 1152-60.
40. Segaloff A. The role of the ovary in the synergism between radiation and estrogen in the production of mammary cancer in the rat. In: Bigazzi M, Greenwood FC, Gasparri F, eds. Biology of relaxin and its role in the human. Amsterdam: Excerpta Medico, 1983; 410-6.
41. Sherwood OD. Relaxin. In: Knobil E, Neill J, eds. The physiology of reproduction. 2nd ed. New York: Raven Press, 1994; 861-1010.
42. Soule HD, Vazquez J, Long A, Albert S, Brennan N. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409-16.
43. Starzec AB, Spanakis E, Nehme A, Salle V, Veber N, Mainguene C, Planchon P, Valette A, Prevost G, Israel L. Proliferative responses of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis. J Cell Physiol 1994; 161: 31-8.
44. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-55.
45. Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang Y, Revankar GR, Crabtree G, Robins RK, Cho-Chung YS. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 1988; 48: 1642-50.
46. Wada H, Turner CW. Role of relaxin in stimulating mammary gland growth in mice. Proc Soc Exp Biol Med 1958, 99: 194-7.
47. Wink DA, Osawa Y, Derbyshire JF, Jones CR, Eshenour SC, Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 1993; 300: 115-23.
48. Yamashita K, Fujita H, Kitajima K, Nishii Y. Inter- and intracellular luminal formation in porcine thyroid tissues cultured in a collagen substrate. Arch Histol Cytol 1989; 52: 109-14.